Egg Incubators,Egg Hatcher Equipment,Fully Automatic Egg Hatcher Equipment,Automatic Egg Hatcher Incubator Jiangsu Minnuo Group Co.,Ltd , https://www.jsminnuomachinery.com
At this time, only two years have passed since the establishment of Optics Valley Biological City. However, the two-year-old biological city has grown into a “big man†and has become a rising industrial star. In June 2007, Wuhan was granted a “National Biological Industry Base†and the Optics Valley Biological City was built in November of the following year. Although Wuhan, the third batch of 12 national-level bio-industrial bases in the country, started its development, the development momentum was strong.
During the construction period, BioCity strived to create six platforms to support the development of the industry: First, the establishment of the Institute of Biotechnology, invited six members including Deng Zixin, Chen Huanchun, and Tian Bo, and introduced 64 research and development teams at home and abroad to form a technical support platform; The national GLP Drug Safety Evaluation Center, the Provincial Food and Drug Safety Evaluation Center and other authoritative organizations formed a public service platform. Third, six professional incubators were established. The national major new drug development and new drug incubator bases were specially evaluated to form a business incubation platform; Fourth, the establishment of an enterprise Investment fund companies and industrial special funds raised hundreds of billions of funds and received more than RMB 3 billion in bank credits to form a investment and financing platform. The fifth was the introduction of 57 high-level talent teams at home and abroad, and international high-end talents joined in the formation of talents. Platform; 6 is to use the Wuhan branch of the Chinese Academy of Sciences as a carrier to build a scientific and technological literature, project investment and financing information sharing platform.
Planting phoenix trees and phoenix come. The world’s largest pharmaceutical company, Pfizer, has settled down. The world's first small molecule drug research and development company WuXing Kangde, China's first biological agricultural breeding enterprise China Seed Group, etc., have come to BioCity. A group of global pharmaceutical industry leaders such as British GlaxoSmithKline and Germany Bayer Pharmaceutical also seized the opportunity to share the feast of the rapid development of BioCity.
In early January, a small-scale project investment promotion conference held in Wuhan Guanggu Biological City attracted more than 100 venture capital, fund, and pharmaceutical R&D institutions, and reached 50 cooperation agreements. According to statistics, Optical Valley Biological City has invested RMB 500 million per square kilometre in capital construction and signed 104 agreement projects. In 2010, the total industrial revenue exceeded RMB 24 billion.